QA: Arcturus Therapeutics Holdings Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001768224_2023_Arcturus_Therapeutics_Holdings_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001768224, Arcturus Therapeutics Holdings Inc.

  xvar xval
0 AssetsCurrent 403,333,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,415,000
3 remainder_Assets 34,639,000
4 LiabilitiesCurrent 126,984,000
5 LiabilitiesNoncurrent 33,020,000
6 remainder_Liabilities 20,071,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 46,071,000
9 ResearchAndDevelopmentExpense 147,751,000
10 remainder_Expenses 1,295,000
11 remainder_Revenues 205,999,000
12 remainder_NetIncome -1,533,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 450,387,000
1 Liabilities 180,075,000
2 Expenses 195,117,000
3 Revenues 205,999,000
4 StockholdersEquity 270,312,000
5 NetIncome 9,349,000
6 ComprehensiveNetIncome 9,349,000
7 BaseVar 516,555,500
8 EconomicCapitalRatio 1.50

Edgar->Model Mapping

Feature Distribution

Change over Time